构建用于组织修复的多价核酸药物
onstructing multivalent nucleic acid drugs for tissue repair
慢性创伤的具有较高的发病率,其实际治愈率大大低于公开的90%。无论是愈合不足还是愈合过度,都会给患者带来巨大的经济负担以及生理痛苦,因此促进组织修复过程对于相关疾病的治疗十分重要。核酸分子具有较高的生物相容性以及可控的分子尺寸,利用DNA纳米技术能够设计靶向FGFR1的DNA配体。此外,多价效应在无膜细胞器的形成,细胞黏附等过程中都具有重要作用,基于多价效应,研究人员已经开发了应用于不同场景的药物分子。在此,本研究在靶向FGFR1的寡核苷酸的基础上,构建了DNA多价配体以调控细胞信号转导,促进细胞增殖迁移以促进组织修复过程。
hronic trauma has a high incidence, and the actual cure rate is much lower than the public 90%. Whether it is insufficient healing or excessive healing, it will bring huge economic burden and physiological pain to patients, so it is very important to promote the process of tissue repair for the treatment of related diseases. Nucleic acid molecules have high biocompatibility and controllable molecular size. DNA nanotechnology can be used to design DNA ligands targeting FGFR1. In addition, the multivalent effect plays an important role in the formation of membraneless organelles and cell adhesion. Based on the polyvalent effect, researchers have developed drug molecules for different scenarios. In this study, on the basis of oligonucleotides targeting FGFR1, DNA multivalent ligands were constructed to regulate cell signal transduction, promote cell proliferation and migration and promote the process of tissue repair.
王雪、王洪辉
药学生物工程学基础医学
组织损伤修复多价效应NA纳米技术bFGF
issue damage repairPolyvalent effectDNA nanotechnologybFGF
王雪,王洪辉.构建用于组织修复的多价核酸药物[EB/OL].(2024-04-15)[2025-07-22].http://www.paper.edu.cn/releasepaper/content/202404-179.点此复制
评论